PQT/VCP March Update
VCP
Active Pharmaceutical Ingredient (API) Prequalified
M
Nirmatrelvir manufactured by DongBang Future Tech & Life Co., Ltd.
PQT/MED: Expanded abridged prequalification pathways
M
According to WHO’s Procedure for prequalification of pharmaceutical products (TRS 961, Annex 10), “WHO recognizes the evaluation of relevant
38th Invitation of Active Pharmaceutical Ingredients (APIs)
M
The following API was added:
Lupin’s ethambutol 100 mg dispersible prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
S Kant’s pyridoxine 10 mg tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
PQT/MED publishes first invitation to manufacturers of medicinal products for treatment of bacterial infections in children to submit an Expression of Interest (EOI) for product evaluation to the WHO Prequalification Unit
M
A first invitation to manufacturers of medicinal products for treatment of bacterial infections in children, to submit an Expression of Interest (EOI) for product evaluation has been published by t
RV Lifesciences’ entecavir products prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
PQT/MED publishes first invitation to manufacturers of Mycobacterium tuberculosis antigen-based skin tests (TBSTs) to submit an Expression of Interest (EOI)
M
A first invitation to manufacturers of Mycobacterium tuberculosis antigen-based skin tests (TBSTs), to submit an Expression of Interest (EOI) for product evaluation has been published by the WHO Pr